MiR-182-3p Targets TRF2 and Impairs Tumor Growth of Triple-Negative Breast Cancer

By performing a high-throughput luciferase screening of 54 candidate miRNAs, the authors identified miR-182-3p as a specific and efficient post-transcriptional regulator of telomeric repeat-binding factor 2 (TRF2).